Add BrightSurf on Google Email

Common gout drug may reduce risk of heart attack and stroke

A Cochrane review found that low-dose colchicine reduced heart attacks and strokes in people with a history of heart disease or stroke. The study involved nearly 23,000 participants and showed that taking colchicine could prevent about two of each heart attack and stroke among those with cardiovascular disease.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 12, 2025

Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function

A comprehensive analysis of 70,000 participants across 10 trials found that SGLT2 inhibitors reduced the risk of chronic kidney disease (CKD) progression by 38% and slowed eGFR decline by 51%. The treatment was beneficial for all levels of kidney function and albuminuria levels, particularly in reducing hospitalizations.

SourceGeorge Institute for Global Health·JournalJAMA·TypeMeta-analysis·DateNov 7, 2025

Disagreement between two kidney function tests predicts serious health problems

A new study reveals that a large gap between two common kidney function tests may indicate future disease, particularly among older adults. The research found that over a third of hospitalized participants had a significant difference in their creatinine and cystatin C readings, which can predict serious health problems.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJAMA·TypeMeta-analysis·DateNov 7, 2025

Fibroblasts: Hidden drivers of heart failure progression

Researchers discovered that cardiac fibroblasts use a signaling pathway to promote harmful changes in the heart, weakening its ability to pump blood efficiently. Blocking this pathway in mice models improved heart function, suggesting that fibroblasts could be a potential target for new therapeutic strategies.

SourceOkayama University·JournalNature Cardiovascular Research·TypeExperimental study·DateOct 29, 2025

GLIS model as a predictor of outcomes in older adults with heart failure

Researchers validate GLIS model as a reliable predictor of sarcopenia and mortality risk in older patients with heart failure, outperforming existing tests. The model's accuracy enables early detection of physical decline and poor prognosis, informing treatment planning and discharge decisions.

SourceJuntendo University Research Promotion Center·JournalEuropean Journal of Preventive Cardiology·TypeObservational study·DateOct 29, 2025

Study reveals clinical frailty scale as a quick predictor of patient risk after heart failure administration

A study found that the Clinical Frailty Scale (CFS) is a quick predictor of patient risk after heart failure administration. The researchers used anonymized patient information from Japan and found that CFS scores were strongly correlated with physical and cognitive impairment, as well as increased mortality risk.

SourceJuntendo University Research Promotion Center·JournalJournal of the American College of Cardiology·TypeData/statistical analysis·DateOct 28, 2025

Biologic drug reduces symptoms, hospitalization for severe pulmonary hypertension after diagnosis

A phase 3 clinical trial found that sotatercept significantly reduces the likelihood of worsening disease in patients with severe pulmonary hypertension when added to standard treatment within the first year after diagnosis. The medication reduced the risk of deterioration by 76% and hospitalizations by nearly half.

SourceMichigan Medicine - University of Michigan·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateSep 30, 2025

American College of Cardiology issues scientific statement on inflammation and cardiovascular disease

The American College of Cardiology has released a scientific statement on inflammation and its connection to various cardiovascular diseases, including coronary artery disease and heart failure. The statement confirms years of research confirming the importance of inflammation as an underlying contributor to CVDs.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateSep 29, 2025

Family Heart Foundation announces recommendations to improve universal screening for underdiagnosed genetic condition in children, which causes early onset cardiovascular disease

A multidisciplinary panel published in the Journal of Pediatrics advocates for accelerated diagnosis of familial hypercholesterolemia, a life-threatening genetic condition. Universal lipid screening is recommended to identify affected children at high risk of heart disease decades earlier than those without the condition.

SourceFamily Heart Foundation·JournalThe Journal of Pediatrics·TypeSystematic review·DateSep 23, 2025

Intense light therapy may lower risk of myocardial injuries after non-cardiac surgery

A study published in Annals of Translational Medicine found that intense light therapy can lower troponin levels and increase ANGPTL4 protein, protecting heart tissue. The treatment may reduce the risk of myocardial injuries after non-cardiac surgery, which affects 20% of patients and increases one-year mortality rates.

SourceUniversity of Colorado Anschutz Medical Campus·JournalAnnals of Translational Medicine·TypeObservational study·DateSep 4, 2025

Wireless implant network could transform cardiac, neurological care

The system uses magnetoelectric power-transfer technology to deliver precise electrical stimulation to organs like the heart and spinal cord. The more devices in the network, the more efficient it is, offering a less invasive alternative to traditional implantable medical devices. This technology has potential for treating conditions s...

SourceRice University·JournalNature Biomedical Engineering·TypeExperimental study·DateAug 28, 2025

New study uncovers how genetics and lifestyle drive the heart disease dilated cardiomyopathy

Researchers found that individuals with a mutation in the TTN gene are 21 times more likely to develop dilated cardiomyopathy than those without. Lifestyle factors such as being overweight or having high alcohol consumption contribute to an earlier diagnosis, and men with the mutation are more likely to develop DCM at a younger age.

SourceVictor Chang Cardiac Research Institute·JournalEuropean Heart Journal·TypeObservational study·DateAug 11, 2025

Study compares common type 2 diabetes drugs, finding higher cardiovascular risk for one medication

A recent study published in JAMA Network Open found that glipizide, a commonly used type 2 diabetes medication, is associated with a 13% increase in cardiovascular risk compared to dipeptidyl peptidase-4 (DPP-4) inhibitors. The study analyzed data from nearly 50,000 patients and found that glipizide was linked to higher rates of heart ...

SourceMass General Brigham·JournalJAMA Network Open·TypeObservational study·DateJul 24, 2025

Patients with heart failure and atrial fibrillation undergoing transcatheter mitral edge-to-edge repair for severe mitral regurgitation are at significantly higher risk of death or rehospitalization

A study from Mount Sinai Hospital found that patients with heart failure and atrial fibrillation who undergo mitral edge-to-edge repair have a doubled risk of death or rehospitalization for heart failure compared to those without AF. The researchers recommend aggressive treatment of AF before the procedure to improve outcomes.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American Heart Association·TypeRandomized controlled/clinical trial·DateJul 17, 2025

Olympians' hearts in focus: groundbreaking study reveals elite rowers' surprising AFib risk

A new study involving 121 former elite rowers from Australia found that one in five develops atrial fibrillation, a condition that can lead to stroke and heart failure. The researchers identified genetic and clinical tools that enable early preventive strategies, highlighting the paradox that AFib is more common among fit athletes.

SourceVictor Chang Cardiac Research Institute·JournalEuropean Heart Journal·TypeObservational study·DateJun 25, 2025

Still top cause of death, the types of heart disease people are dying from is changing

Research reveals significant drop in heart attack deaths, while increases observed in deaths from heart failure, arrhythmias, and hypertensive heart disease over the past 50 years. Studies suggest advancements in medical treatment, bystander CPR, and public health initiatives have contributed to these findings.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateJun 25, 2025

Large global study links severe bleeding after childbirth to increased risk of cardiovascular disease

A large global study found that women who experience severe bleeding after childbirth face an increased risk of cardiovascular conditions, including heart failure and ischemic heart disease, for up to 15 years. The study analyzed data from over 9.7 million women across Europe, North America, and Asia.

SourceTaylor & Francis Group·JournalThe Journal of Maternal-Fetal & Neonatal Medicine·TypeLiterature review·DateJun 25, 2025